Mounjaro

Product

Eli Lilly's injectable tirzepatide brand for type 2 diabetes

2 stories

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections